Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v28-EN Version v10-EN
Language English English
Date Updated 2019-02-16 2018-10-04
Drug Identification Number 02398435 02398435
Brand name MYLAN-ALMOTRIPTAN MYLAN-ALMOTRIPTAN
Common or Proper name ALMOTRIPTAN ALMOTRIPTAN
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients ALMOTRIPTAN ALMOTRIPTAN
Strength(s) 6.25MG 6.25MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 6BL 6BL
ATC code N02CC N02CC
ATC description ANTIMIGRAINE PREPARATIONS ANTIMIGRAINE PREPARATIONS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2018-10-03 2018-10-03
Actual start date 2018-10-03
Estimated end date 2019-02-15 2018-11-16
Actual end date 2019-02-15
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments